Latest News

  • London, UK – Subtle changes in the brain, detectable through advanced imaging, blood and spinal fluid analysis, happen approximately twenty years before a clinical motor diagnosis in people with Huntington’s disease, finds a new study led by UCL researchers. The research, published in Nature Medicine, was in collaboration with experts...
  • Melbourne, Australia – Cigarette smoking is widespread and deadly, yet our understanding of how cigarette smoke actually causes serious respiratory illnesses is incomplete, which has severely hampered the development of effective treatments. Today, Australian researchers reveal how multiple chemicals found in cigarette smoke and e-cigarettes alter the function of a...
  • CAMBRIDGE, Mass. — Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and pyruvate kinase (PK) activation pioneering therapies for rare diseases, today announced its anticipated key 2025 milestones and value-driving catalysts through 2026. “2024 was marked by exceptional progress at Agios. We delivered on all our key priorities,...

Videos

Rare disease spotlight

Twitter

[custom-twitter-feeds]